1082428-27-0 Usage
Description
3-Methyl-[1,2,4]triazolo[4,3-a]pyridin-6-aMine is a chemical compound that belongs to the class of triazolopyridine derivatives. It is a small molecule characterized by its molecular formula C7H7N5 and a molecular weight of 149.16 g/mol. 3-Methyl-[1,2,4]triazolo[4,3-a]pyridin-6-aMine is utilized in various pharmaceutical and chemical research applications, serving as a building block in the synthesis of pharmaceutical drugs and in organic chemistry. Due to its potential hazards and risks, it is crucial to handle this chemical with care and follow proper safety protocols.
Uses
Used in Pharmaceutical Industry:
3-Methyl-[1,2,4]triazolo[4,3-a]pyridin-6-aMine is used as a building block for the synthesis of pharmaceutical drugs. Its unique structure and properties make it a valuable component in the development of new medications, contributing to the advancement of drug discovery and therapeutics.
Used in Chemical Research:
In the field of chemical research, 3-Methyl-[1,2,4]triazolo[4,3-a]pyridin-6-aMine is employed as a key component in various organic chemistry studies. Its versatile chemical properties allow for its use in the exploration of new chemical reactions and the synthesis of novel compounds, further expanding the scope of chemical knowledge and applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1082428-27-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,8,2,4,2 and 8 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1082428-27:
(9*1)+(8*0)+(7*8)+(6*2)+(5*4)+(4*2)+(3*8)+(2*2)+(1*7)=140
140 % 10 = 0
So 1082428-27-0 is a valid CAS Registry Number.
1082428-27-0Relevant articles and documents
SUBSTITUTED OXOPYRIDINE DERIVATIVES
-
Paragraph 0551; 0552; 0553, (2016/10/11)
The invention relates to substituted oxopyridine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.
